Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 49

1.

Hepatitis C Virus Infection and the Temporal Trends in the Risk of Liver Cancer: A National Register-Based Cohort Study in Sweden.

Batyrbekova N, Aleman S, Lybeck C, Montgomery S, Duberg AS.

Cancer Epidemiol Biomarkers Prev. 2020 Jan;29(1):63-70. doi: 10.1158/1055-9965.EPI-19-0769. Epub 2019 Nov 12.

2.

Prevalence of Viremic hepatitis C, hepatitis B, and HIV infection, and vaccination status among prisoners in Stockholm County.

Gahrton C, Westman G, Lindahl K, Öhrn F, Dalgard O, Lidman C, Nilsson LH, Said K, Duberg AS, Aleman S.

BMC Infect Dis. 2019 Nov 9;19(1):955. doi: 10.1186/s12879-019-4581-3.

3.

Management of hepatitis B virus infection, updated Swedish guidelines.

Westin J, Aleman S, Castedal M, Duberg AS, Eilard A, Fischler B, Kampmann C, Lindahl K, Lindh M, Norkrans G, Stenmark S, Weiland O, Wejstål R.

Infect Dis (Lond). 2020 Jan;52(1):1-22. doi: 10.1080/23744235.2019.1675903. Epub 2019 Oct 15.

PMID:
31613181
4.

Lipophilic Statins and Risk for Hepatocellular Carcinoma and Death in Patients With Chronic Viral Hepatitis: Results From a Nationwide Swedish Population.

Simon TG, Duberg AS, Aleman S, Hagstrom H, Nguyen LH, Khalili H, Chung RT, Ludvigsson JF.

Ann Intern Med. 2019 Sep 3;171(5):318-327. doi: 10.7326/M18-2753. Epub 2019 Aug 20.

PMID:
31426090
5.

Effect of the baseline Y93H resistance-associated substitution in HCV genotype 3 for direct-acting antiviral treatment: real-life experience from a multicenter study in Sweden and Norway.

Kjellin M, Kileng H, Akaberi D, Palanisamy N, Duberg AS, Danielsson A, Kristiansen MG, Nöjd J, Aleman S, Gutteberg T, Goll R, Lannergård A, Lennerstrand J.

Scand J Gastroenterol. 2019 Aug;54(8):1042-1050. doi: 10.1080/00365521.2019.1652846. Epub 2019 Aug 19.

PMID:
31424972
6.

The Consensus Hepatitis C Cascade of Care: Standardized Reporting to Monitor Progress Toward Elimination.

Safreed-Harmon K, Blach S, Aleman S, Bollerup S, Cooke G, Dalgard O, Dillon JF, Dore GJ, Duberg AS, Grebely J, Boe Kielland K, Midgard H, Porter K, Razavi H, Tyndall M, Weis N, Lazarus JV.

Clin Infect Dis. 2019 Nov 27;69(12):2218-2227. doi: 10.1093/cid/ciz714.

PMID:
31352481
7.

Long-term follow-up after cure from chronic hepatitis C virus infection shows occult hepatitis and a risk of hepatocellular carcinoma in noncirrhotic patients.

Lybeck C, Brenndörfer ED, Sällberg M, Montgomery SM, Aleman S, Duberg AS.

Eur J Gastroenterol Hepatol. 2019 Apr;31(4):506-513. doi: 10.1097/MEG.0000000000001316.

8.

Personalized treatment of hepatitis C genotype 1a in Norway and Sweden 2014-2016: a study of treatment outcome in patients with or without resistance-based DAA-therapy.

Kileng H, Kjellin M, Akaberi D, Bergfors A, Duberg AS, Wesslén L, Danielsson A, Gangsøy Kristiansen M, Gutteberg T, Goll R, Lannergård A, Lennerstrand J.

Scand J Gastroenterol. 2018 Oct - Nov;53(10-11):1347-1353. doi: 10.1080/00365521.2018.1511824. Epub 2018 Nov 5.

PMID:
30394152
9.

Treatment of hepatitis C virus infection for adults and children: updated Swedish consensus guidelines 2017.

Lagging M, Wejstål R, Duberg AS, Aleman S, Weiland O, Westin J; ; for the Swedish Consensus Group.

Infect Dis (Lond). 2018 Aug;50(8):569-583. doi: 10.1080/23744235.2018.1445281. Epub 2018 Mar 1. Review.

PMID:
29495923
10.

Availability of hepatitis C diagnostics and therapeutics in European and Eurasia countries.

Leblebicioglu H, Arends JE, Ozaras R, Corti G, Santos L, Boesecke C, Ustianowski A, Duberg AS, Ruta S, Salkic NN, Husa P, Lazarevic I, Pineda JA, Pshenichnaya NY, Tsertswadze T, Matičič M, Puca E, Abuova G, Gervain J, Bayramli R, Ahmeti S, Koulentaki M, Kilani B, Vince A, Negro F, Sunbul M, Salmon D; ESGHV (part of ESCMID).

Antiviral Res. 2018 Feb;150:9-14. doi: 10.1016/j.antiviral.2017.12.001. Epub 2017 Dec 5.

PMID:
29217468
11.

Lack of Association Between Interleukin 28B Polymorphism and Vertical Transmission of Hepatitis C.

Psaros Einberg A, Duberg AS, Filipovich O, Nyström J, Zhirkov A, Brenndörfer ED, Frelin L, Rukoiatkina E, Lobzin Y, Sällberg M, Fischler B, Lutckii A.

J Pediatr Gastroenterol Nutr. 2017 Dec;65(6):608-612. doi: 10.1097/MPG.0000000000001711.

PMID:
28820758
12.

Long-term liver-related morbidity and mortality related to chronic hepatitis C virus infection in Swedish patients with inherited bleeding disorders.

Holmström M, Nangarhari A, Öhman J, Duberg AS, Majeed A, Aleman S.

Haemophilia. 2016 Nov;22(6):e494-e501. doi: 10.1111/hae.13020. Epub 2016 Oct 5.

PMID:
27704656
13.

Prevalence and comorbidities of chronic hepatitis C: a nationwide population-based register study in Sweden.

Büsch K, Waldenström J, Lagging M, Aleman S, Weiland O, Kövamees J, Duberg AS, Söderholm J.

Scand J Gastroenterol. 2017 Jan;52(1):61-68. doi: 10.1080/00365521.2016.1228119. Epub 2016 Sep 6.

PMID:
27598393
14.

The underreporting of hepatocellular carcinoma to the cancer register and a log-linear model to estimate a more correct incidence.

Törner A, Stokkeland K, Svensson Å, Dickman PW, Hultcrantz R, Montgomery S, Duberg AS.

Hepatology. 2017 Mar;65(3):885-892. doi: 10.1002/hep.28775. Epub 2016 Sep 30.

PMID:
27533761
15.

"I feel free": Experiences of a dance intervention for adolescent girls with internalizing problems.

Duberg A, Möller M, Sunvisson H.

Int J Qual Stud Health Well-being. 2016 Jul 12;11:31946. doi: 10.3402/qhw.v11.31946. eCollection 2016.

16.

The future disease burden of hepatitis C virus infection in Sweden and the impact of different treatment strategies.

Duberg AS, Blach S, Falconer K, Kåberg M, Razavi H, Aleman S.

Scand J Gastroenterol. 2015 Feb;50(2):233-44. doi: 10.3109/00365521.2014.990505. Epub 2014 Dec 17.

PMID:
25515032
17.

Strategies to manage hepatitis C virus (HCV) disease burden.

Wedemeyer H, Duberg AS, Buti M, Rosenberg WM, Frankova S, Esmat G, Örmeci N, Van Vlierberghe H, Gschwantler M, Akarca U, Aleman S, Balık I, Berg T, Bihl F, Bilodeau M, Blasco AJ, Brandão Mello CE, Bruggmann P, Calinas F, Calleja JL, Cheinquer H, Christensen PB, Clausen M, Coelho HS, Cornberg M, Cramp ME, Dore GJ, Doss W, El-Sayed MH, Ergör G, Estes C, Falconer K, Félix J, Ferraz ML, Ferreira PR, García-Samaniego J, Gerstoft J, Giria JA, Gonçales FL Jr, Guimarães Pessôa M, Hézode C, Hindman SJ, Hofer H, Husa P, Idilman R, Kåberg M, Kaita KD, Kautz A, Kaymakoglu S, Krajden M, Krarup H, Laleman W, Lavanchy D, Lázaro P, Marinho RT, Marotta P, Mauss S, Mendes Correa MC, Moreno C, Müllhaupt B, Myers RP, Nemecek V, Øvrehus AL, Parkes J, Peltekian KM, Ramji A, Razavi H, Reis N, Roberts SK, Roudot-Thoraval F, Ryder SD, Sarmento-Castro R, Sarrazin C, Semela D, Sherman M, Shiha GE, Sperl J, Stärkel P, Stauber RE, Thompson AJ, Urbanek P, Van Damme P, van Thiel I, Vandijck D, Vogel W, Waked I, Weis N, Wiegand J, Yosry A, Zekry A, Negro F, Sievert W, Gower E.

J Viral Hepat. 2014 May;21 Suppl 1:60-89. doi: 10.1111/jvh.12249.

PMID:
24713006
18.

The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm.

Razavi H, Waked I, Sarrazin C, Myers RP, Idilman R, Calinas F, Vogel W, Mendes Correa MC, Hézode C, Lázaro P, Akarca U, Aleman S, Balık I, Berg T, Bihl F, Bilodeau M, Blasco AJ, Brandão Mello CE, Bruggmann P, Buti M, Calleja JL, Cheinquer H, Christensen PB, Clausen M, Coelho HS, Cramp ME, Dore GJ, Doss W, Duberg AS, El-Sayed MH, Ergör G, Esmat G, Falconer K, Félix J, Ferraz ML, Ferreira PR, Frankova S, García-Samaniego J, Gerstoft J, Giria JA, Gonçales FL Jr, Gower E, Gschwantler M, Guimarães Pessôa M, Hindman SJ, Hofer H, Husa P, Kåberg M, Kaita KD, Kautz A, Kaymakoglu S, Krajden M, Krarup H, Laleman W, Lavanchy D, Marinho RT, Marotta P, Mauss S, Moreno C, Murphy K, Negro F, Nemecek V, Örmeci N, Øvrehus AL, Parkes J, Pasini K, Peltekian KM, Ramji A, Reis N, Roberts SK, Rosenberg WM, Roudot-Thoraval F, Ryder SD, Sarmento-Castro R, Semela D, Sherman M, Shiha GE, Sievert W, Sperl J, Stärkel P, Stauber RE, Thompson AJ, Urbanek P, Van Damme P, van Thiel I, Van Vlierberghe H, Vandijck D, Wedemeyer H, Weis N, Wiegand J, Yosry A, Zekry A, Cornberg M, Müllhaupt B, Estes C.

J Viral Hepat. 2014 May;21 Suppl 1:34-59. doi: 10.1111/jvh.12248.

PMID:
24713005
19.

Historical epidemiology of hepatitis C virus (HCV) in selected countries.

Bruggmann P, Berg T, Øvrehus AL, Moreno C, Brandão Mello CE, Roudot-Thoraval F, Marinho RT, Sherman M, Ryder SD, Sperl J, Akarca U, Balık I, Bihl F, Bilodeau M, Blasco AJ, Buti M, Calinas F, Calleja JL, Cheinquer H, Christensen PB, Clausen M, Coelho HS, Cornberg M, Cramp ME, Dore GJ, Doss W, Duberg AS, El-Sayed MH, Ergör G, Esmat G, Estes C, Falconer K, Félix J, Ferraz ML, Ferreira PR, Frankova S, García-Samaniego J, Gerstoft J, Giria JA, Gonçales FL Jr, Gower E, Gschwantler M, Guimarães Pessôa M, Hézode C, Hofer H, Husa P, Idilman R, Kåberg M, Kaita KD, Kautz A, Kaymakoglu S, Krajden M, Krarup H, Laleman W, Lavanchy D, Lázaro P, Marotta P, Mauss S, Mendes Correa MC, Müllhaupt B, Myers RP, Negro F, Nemecek V, Örmeci N, Parkes J, Peltekian KM, Ramji A, Razavi H, Reis N, Roberts SK, Rosenberg WM, Sarmento-Castro R, Sarrazin C, Semela D, Shiha GE, Sievert W, Stärkel P, Stauber RE, Thompson AJ, Urbanek P, van Thiel I, Van Vlierberghe H, Vandijck D, Vogel W, Waked I, Wedemeyer H, Weis N, Wiegand J, Yosry A, Zekry A, Van Damme P, Aleman S, Hindman SJ.

J Viral Hepat. 2014 May;21 Suppl 1:5-33. doi: 10.1111/jvh.12247. Review.

PMID:
24713004
20.

Risk of pancreatic cancer among individuals with hepatitis C or hepatitis B virus infection: a nationwide study in Sweden.

Huang J, Magnusson M, Törner A, Ye W, Duberg AS.

Br J Cancer. 2013 Nov 26;109(11):2917-23. doi: 10.1038/bjc.2013.689. Epub 2013 Oct 31.

21.

[Dance can serve as a protective factor in preventing mental illness].

Duberg A, Möller M, Taube J.

Lakartidningen. 2013 Sep 4-10;110(36):1539-41. Review. Swedish. No abstract available.

PMID:
24163907
22.

[Important with generous sampling for hepatitis C after blood transfusion. The National Board of Health and Welfare's new recommendation for risk groups].

Duberg AS, Hansdotter F, How AL, Holmström A, Lesko B.

Lakartidningen. 2013 Aug 21-Sep 3;110(34-35):1477-9. Swedish. No abstract available.

PMID:
24044185
23.

Something about the dance.

Duberg A.

Arch Pediatr Adolesc Med. 2012 Nov 1;166(11):1037-44. doi: 10.1001/archpediatrics.2012.328. No abstract available.

PMID:
23754063
24.

Implications of baseline polymorphisms for potential resistance to NS3 protease inhibitors in Hepatitis C virus genotypes 1a, 2b and 3a.

Palanisamy N, Danielsson A, Kokkula C, Yin H, Bondeson K, Wesslén L, Duberg AS, Lennerstrand J.

Antiviral Res. 2013 Jul;99(1):12-7. doi: 10.1016/j.antiviral.2013.04.018. Epub 2013 May 3.

PMID:
23648709
25.

Cost-utility analysis of a dance intervention for adolescent girls with internalizing problems.

Philipsson A, Duberg A, Möller M, Hagberg L.

Cost Eff Resour Alloc. 2013 Feb 20;11(1):4. doi: 10.1186/1478-7547-11-4.

26.

Influencing self-rated health among adolescent girls with dance intervention: a randomized controlled trial.

Duberg A, Hagberg L, Sunvisson H, Möller M.

JAMA Pediatr. 2013 Jan;167(1):27-31. doi: 10.1001/jamapediatrics.2013.421.

PMID:
23403597
27.

Treatment of hepatitis C virus infection in adults and children: updated Swedish consensus recommendations.

Lagging M, Duberg AS, Wejstål R, Weiland O, Lindh M, Aleman S, Josephson F; Swedish Consensus Group.

Scand J Infect Dis. 2012 Jul;44(7):502-21. doi: 10.3109/00365548.2012.669045. Epub 2012 Apr 16. Review.

PMID:
22506634
28.

A method to visualize and adjust for selection bias in prevalent cohort studies.

Törner A, Dickman P, Duberg AS, Kristinsson S, Landgren O, Björkholm M, Svensson Å.

Am J Epidemiol. 2011 Oct 15;174(8):969-76. doi: 10.1093/aje/kwr211. Epub 2011 Sep 13.

PMID:
21920949
29.

Risk of kidney cancer and chronic kidney disease in relation to hepatitis C virus infection: a nationwide register-based cohort study in Sweden.

Hofmann JN, Törner A, Chow WH, Ye W, Purdue MP, Duberg AS.

Eur J Cancer Prev. 2011 Jul;20(4):326-30. doi: 10.1097/CEJ.0b013e32834572fa.

30.

[Permanent hearing loss following dog bite. Capnocytophaga canimorsus caused severe infection with sepsis].

Widlund M, Duberg AS.

Lakartidningen. 2010 Jul 21-Aug 10;107(29-31):1771-3. Swedish. No abstract available.

PMID:
20812562
31.

Hepatocellular carcinoma in individuals with HBV infection or HBV-HCV co-infection in a low endemic country.

Davídsdóttir L, Duberg AS, Törner A, Aleman S, Bäck E, Ekdahl K, Blaxhult A, Ekbom A, Hultcrantz R.

Scand J Gastroenterol. 2010 Aug;45(7-8):944-52. doi: 10.3109/00365521003770251.

PMID:
20384529
32.

The burden of hepatitis C in Sweden: a national study of inpatient care.

Duberg AS, Pettersson H, Aleman S, Blaxhult A, Daviðsdóttir L, Hultcrantz R, Bäck E, Ekdahl K, Montgomery SM.

J Viral Hepat. 2011 Feb;18(2):106-18. doi: 10.1111/j.1365-2893.2010.01276.x.

PMID:
20158602
33.

A proposed method to adjust for selection bias in cohort studies.

Törner A, Duberg AS, Dickman P, Svensson A.

Am J Epidemiol. 2010 Mar 1;171(5):602-8. doi: 10.1093/aje/kwp432. Epub 2010 Jan 27.

PMID:
20106936
34.

Misleading figures on trends in mortality from hepatocellular carcinoma in Europe.

Duberg AS, Hultcrantz R.

Hepatology. 2009 Jan;49(1):336; author reply 336-7. doi: 10.1002/hep.22671. No abstract available.

PMID:
19035339
35.

The epidemiology of hepatitis C virus infection in Sweden.

Duberg A, Janzon R, Bäck E, Ekdahl K, Blaxhult A.

Euro Surveill. 2008 May 22;13(21). pii: 18882.

36.

Treatment of chronic hepatitis B infection: an update of Swedish recommendations.

Lindh M, Uhnoo I, Bläckberg J, Duberg AS, Friman S, Fischler B, Karlström O, Norkrans G, Reichard O, Sangfeldt P, Söderström A, Sönnerborg A, Weiland O, Wejstål R, Wiström J.

Scand J Infect Dis. 2008;40(6-7):436-50. doi: 10.1080/00365540802154769. Review.

PMID:
18584530
37.

Hepatocellular carcinoma and other primary liver cancers in hepatitis C patients in Sweden - a low endemic country.

Strauss R, Törner A, Duberg AS, Hultcrantz R, Ekdahl K.

J Viral Hepat. 2008 Jul;15(7):531-7. doi: 10.1111/j.1365-2893.2008.00979.x. Epub 2008 Apr 4.

PMID:
18397224
38.

Cause of death in individuals with chronic HBV and/or HCV infection, a nationwide community-based register study.

Duberg AS, Törner A, Davidsdóttir L, Aleman S, Blaxhult A, Svensson A, Hultcrantz R, Bäck E, Ekdahl K.

J Viral Hepat. 2008 Jul;15(7):538-50. doi: 10.1111/j.1365-2893.2008.00982.x. Epub 2008 Apr 4.

PMID:
18397223
39.

Non-Hodgkin's lymphoma and other nonhepatic malignancies in Swedish patients with hepatitis C virus infection.

Duberg AS, Nordström M, Törner A, Reichard O, Strauss R, Janzon R, Bäck E, Ekdahl K.

Hepatology. 2005 Mar;41(3):652-9.

PMID:
15723449
40.

Reduction of radiculopathy and pain with Oxiplex/SP gel after laminectomy, laminotomy, and discectomy: a pilot clinical study.

Kim KD, Wang JC, Robertson DP, Brodke DS, Olson EM, Duberg AC, BenDebba M, Block KM, diZerega GS.

Spine (Phila Pa 1976). 2003 May 15;28(10):1080-7; discussion 1087-8.

PMID:
12768153
41.

Coccidioidal spondylitis: MR findings in 15 patients.

Olson EM, Duberg AC, Herron LD, Kissel P, Smilovitz D.

AJR Am J Roentgenol. 1998 Sep;171(3):785-9.

PMID:
9725317
42.

Virological, biochemical and histological effects of human lymphoblastoid interferon in Swedish patients with chronic hepatitis C.

Garson JA, Uhnoo I, Whitby K, Braconier JH, Deaville R, Duberg A, Wallmark E, Wiström J, Goldin RD, Spacey B.

J Viral Hepat. 1997 Sep;4(5):325-31.

PMID:
9310931
43.

Transmission of hepatitis C virus by transfusion in Orebro County, Sweden, 1990-1992.

Norda R, Duberg AS, Sönnerborg A, Olcén P.

Scand J Infect Dis. 1995;27(5):449-52.

PMID:
8588133
44.

Intracranial cryptococcosis in immunocompromised patients: CT and MR findings in 29 cases.

Tien RD, Chu PK, Hesselink JR, Duberg A, Wiley C.

AJNR Am J Neuroradiol. 1991 Mar-Apr;12(2):283-9.

PMID:
1902029
45.

An evaluation of MRI contrast in the uterus using synthetic imaging.

Lange RC, Duberg AC, McCarthy SM.

Magn Reson Med. 1991 Jan;17(1):279-84.

PMID:
2067403
46.

Rare subependymal giant-cell astrocytoma in a neonate with tuberous sclerosis.

Tien RD, Hesselink JR, Duberg A.

AJNR Am J Neuroradiol. 1990 Nov-Dec;11(6):1251-2. No abstract available.

PMID:
2124070
47.

Superior oblique tendon sheath syndrome (Brown syndrome): MR findings.

Tien RD, Duberg A, Chu PK, Bessette J, Hesselink JR, Hazelhurst JA.

AJNR Am J Neuroradiol. 1990 Nov-Dec;11(6):1210. No abstract available.

PMID:
2124062
48.

Radiolabeled fibronectin for the scintigraphic detection of pulmonary emboli in dogs.

Zoghbi SS, Sostman HD, Duberg AC, Lwebuga-Mukasa J, Carbo PL, Gottschalk A.

Invest Radiol. 1988 Aug;23(8):574-8.

PMID:
3417434
49.

A comparison between Bactec aerobic resin and hypertonic blood culture media.

Sjöberg L, Fredlund H, Duberg AS.

APMIS. 1988 Aug;96(8):720-2.

PMID:
3415846

Supplemental Content

Loading ...
Support Center